Product Information
SIROLIMUS 1 MG/ML SOLUTION is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $4.3903 per ML under NDC 59762120506. Its NADAC has been published 234 times since Feb 17, 2021.
FDA first approved this application on Sep 15, 1999. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762120506
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SIROLIMUSApproval Type
Authorized Generic (NDA)
FDA Application
NDA021083FDA Approved
9/15/1999
TE Code
AA
On Market Since
7/22/2019
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 1 MG/ML SOLUTION has been published 234 times since Feb 17, 2021, and over the history we have for it it has declined 73.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3903 per ML |
|---|---|
| All-time high | $16.6782 (Feb 16, 2022) |
| All-time low | $4.3903 (Sep 23, 2026) |
| 52-week high | $5.2539 |
| 52-week low | $4.3903 |
| Median price | $7.0339 |
| Average price | $8.6558 |
| Largest weekly change | -48.4% (Feb 23, 2022) |
| Weeks tracked | 234 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sirolimus market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Kinase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIROLIMUS 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 1 MG/ML SOLUTION, manufactured by Mylan Pharmaceuticals Inc., is $4.3903 per ML (NDC 59762120506), effective Sep 30, 2026.
How has the price of SIROLIMUS 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 1 MG/ML SOLUTION has declined 73.7%. It has been tracked across 234 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 1 MG/ML SOLUTION?
Since Feb 17, 2021, the NADAC for SIROLIMUS 1 MG/ML SOLUTION has ranged from a low of $4.3903 (Sep 23, 2026) to a high of $16.6782 (Feb 16, 2022), with a median of $7.0339 per ML.
Are there cheaper alternatives to SIROLIMUS 1 MG/ML SOLUTION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SIROLIMUS 1 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures SIROLIMUS 1 MG/ML SOLUTION?
SIROLIMUS 1 MG/ML SOLUTION (NDC 59762120506) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.